Editorial commentary: meniscal tissue engineering.

Area of Science:

• Biomaterials Science
• Regenerative Medicine
• Orthopedic Surgery

Background:

• Meniscal tissue engineering aims to regenerate damaged knee meniscus using a combination of cellular, material, and stimulation-based strategies.
• Key components include viable cells, biocompatible scaffolds, potent growth factors, and both biomechanical and biochemical stimulation protocols.
• Extensive preclinical investigations have been conducted to optimize these strategies for meniscal repair.

Discussion:

• The translation of preclinical meniscal tissue engineering successes to clinical practice remains a significant hurdle.
• A critical review of the current literature reveals a lack of published clinical reports detailing meniscal tissue engineering applications.
• This absence highlights a gap between laboratory findings and real-world patient treatments.

Key Insights:

• Meniscal tissue engineering is a complex, multi-component field requiring significant preclinical development.
• Despite rigorous research, the clinical application of engineered meniscus is not yet documented in scientific literature.
• The transition from preclinical success to clinical reality for meniscal regeneration is not yet established.

Outlook:

• Future research should focus on bridging the gap between preclinical efficacy and clinical translation for meniscal tissue engineering.
• Further investigation into the long-term safety and efficacy of engineered meniscal grafts in human trials is warranted.
• Establishing standardized clinical protocols will be crucial for the successful implementation of meniscal tissue engineering therapies.